Brought to you by 
Curetis signs two exclusive distributors for its Unyvero platform and pneumonia diagnostic
05 Nov 2012
Executive Summary
Curetis AG (molecular diagnostics) has signed two exclusive distribution agreements within a day of each other for the Unyvero platform and Unyvero P50 pneumonia application. Mediphos Group BV’s Mediphos Medical Supplies BV will distribute the products in the Netherlands and BioLine LLC will handle Russia, Ukraine, Kazakhstan, and Belorus.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Curetis signs two exclusive distributors for its Unyvero platform and pneumonia diagnostic
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice